Related Experiment Videos
Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding
R W Kriwacki1, L Hengst, L Tennant
1Department of Molecular Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
Abstract:
The cyclin-dependent kinase (Cdk) inhibitor p21Waf1/Cip1/Sdi1, important for p53-dependent cell cycle control, mediates G1/S arrest through inhibition of Cdks and possibly through inhibition of DNA replication. Cdk inhibition requires a sequence of approximately 60 amino acids within the p21 NH2 terminus. We show, using proteolytic mapping, circular dichroism spectropolarimetry, and nuclear magnetic resonance spectroscopy, that p21 and NH2-terminal fragments that are active as Cdk inhibitors lack stable secondary or tertiary structure in the free solution state. In sharp contrast to the disordered free state, however, the p21 NH2 terminus adopts an ordered stable conformation when bound to Cdk2, as shown directly by NMR spectroscopy. We have, thus, identified a striking disorder-order transition for p21 upon binding to one of its biological targets, Cdk2. This structural transition has profound implications in light of the ability of p21 to bind and inhibit a diverse family of cyclin-Cdk complexes, including cyclin A-Cdk2, cyclin E-Cdk2, and cyclin D-Cdk4. Our findings suggest that the flexibility, or disorder, of free p21 is associated with binding diversity and offer insights into the role for structural disorder in mediating binding specificity in biological systems. Further, these observations challenge the generally accepted view of proteins that stable secondary and tertiary structure are prerequisites for biological activity and suggest that a broader view of protein structure should be considered in the context of structure-activity relationships.
Insights
The cyclin-dependent kinase inhibitor p21Waf1/Cip1/Sdi1 is disordered in solution but becomes structured when binding to Cdk2. This flexibility is key to its ability to inhibit various cyclin-Cdk complexes.
Area of Science:
- Molecular Biology
- Structural Biology
- Biochemistry
Background:
- p21Waf1/Cip1/Sdi1 is a crucial inhibitor of cyclin-dependent kinases (Cdks) involved in p53-dependent cell cycle control.
- p21 mediates G1/S arrest by inhibiting Cdks and potentially DNA replication, with Cdk inhibition localized to its N-terminus.
Purpose of the Study:
- To investigate the structural properties of p21 and its N-terminal fragments.
- To elucidate the structural changes of p21 upon binding to its biological target, Cdk2.
- To understand the implications of p21's structural flexibility on its binding diversity and specificity.
Main Methods:
- Proteolytic mapping
- Circular dichroism spectropolarimetry
- Nuclear magnetic resonance (NMR) spectroscopy
Main Results:
- p21 and its active N-terminal fragments exhibit a lack of stable secondary or tertiary structure in free solution.
- Upon binding to Cdk2, the p21 N-terminus undergoes a disorder-to-order transition, adopting a stable, ordered conformation.
- This structural transition was directly observed using NMR spectroscopy.
Conclusions:
- The inherent disorder of free p21 is crucial for its ability to bind and inhibit a wide range of cyclin-Cdk complexes.
- Structural disorder plays a significant role in mediating binding specificity in biological systems.
- These findings challenge the traditional view that stable structure is a prerequisite for protein activity, suggesting a broader perspective on structure-activity relationships.